APA (7th ed.) Citation

Roney, M., Issahaku, A. R., Tufail, N., Wilhelm, A., & Mohd Fadhlizil Fasihi, M. A. (2024). Computational screening of FDA-approved hepatitis c drugs for inhibition of VEGFR2 in liver cancer. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Chicago Style (17th ed.) Citation

Roney, Miah, Abdul Rashid Issahaku, Nasir Tufail, Anke Wilhelm, and Mohd Aluwi Mohd Fadhlizil Fasihi. Computational Screening of FDA-approved Hepatitis C Drugs for Inhibition of VEGFR2 in Liver Cancer. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, 2024.

MLA (9th ed.) Citation

Roney, Miah, et al. Computational Screening of FDA-approved Hepatitis C Drugs for Inhibition of VEGFR2 in Liver Cancer. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, 2024.